Schedule 13G ownership disclosure

REVANCE THERAPEUTICS INC

Security class unavailable · CUSIP: 761330109

Event date: 2024-09-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,642,448
Percent of class
1.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-24-000588
Form type
SC 13G
Filer
Beryl Capital Management LLC
CIK
CIK 1719307
Filed
Sep 16, 2024
Reporting period
Sep 05, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub